603087 甘李药业
已收盘 07-22 15:00:00
资讯
新帖
简况
最高减重20%！礼来“替尔泊肽”在华获批，效果强过司美格鲁肽？
格隆汇 · 10:20
最高减重20%！礼来“替尔泊肽”在华获批，效果强过司美格鲁肽？
减肥药赛道“搅局者”来了，两大巨头“硬碰硬”
中国基金报 · 07-20 00:14
减肥药赛道“搅局者”来了，两大巨头“硬碰硬”
甘李药业07月18日遭主力抛售786万元 环比增加151.12%
自选股智能写手 · 07-18
甘李药业07月18日遭主力抛售786万元 环比增加151.12%
甘李药业： 考虑运输、成本等因素，海外出口以原料药为主
证券之星 · 07-16
甘李药业： 考虑运输、成本等因素，海外出口以原料药为主
一个赚2亿，一个赔2亿！国产胰岛素“双雄争霸赛”未完待续
中国商报 · 07-16
一个赚2亿，一个赔2亿！国产胰岛素“双雄争霸赛”未完待续
甘李药业07月15日遭主力抛售3272万元 环比增加110.96%
自选股智能写手 · 07-15
甘李药业07月15日遭主力抛售3272万元 环比增加110.96%
全球首款胰岛素周制剂在美遇挫，FDA要求补充信息，今年或无望获批
时代财经 · 07-12
全球首款胰岛素周制剂在美遇挫，FDA要求补充信息，今年或无望获批
再登双榜 | 甘李药业入选《2024中国药品研发实力排行榜》系列榜单
甘李药业 · 07-11
再登双榜 | 甘李药业入选《2024中国药品研发实力排行榜》系列榜单
公司快评︱甘李药业与通化东宝业绩分化 积极适应市场变化才是真龙头
每日经济新闻 · 07-11
公司快评︱甘李药业与通化东宝业绩分化 积极适应市场变化才是真龙头
甘李药业(603087.SH)：磷酸西格列汀片预计将于下半年原研产品专利到期后上市销售
格隆汇资讯 · 07-10
甘李药业(603087.SH)：磷酸西格列汀片预计将于下半年原研产品专利到期后上市销售
甘李药业07月10日主力资金流出220万元 连续7日减仓
自选股智能写手 · 07-10
甘李药业07月10日主力资金流出220万元 连续7日减仓
甘李药业(603087)：业绩超预期 海内外业务齐发力
国泰君安证券股... · 07-09
甘李药业(603087)：业绩超预期 海内外业务齐发力
独家药品概念盘中拉升，甘李药业涨5.05%
自选股智能写手 · 07-09
独家药品概念盘中拉升，甘李药业涨5.05%
甘李药业7月8日获北向资金加仓94.28万股
自选股智能写手 · 07-09
甘李药业7月8日获北向资金加仓94.28万股
甘李药业：预计2024年1-6月归属净利润盈利2.9亿元至3.3亿元
证券之星 · 07-08
甘李药业：预计2024年1-6月归属净利润盈利2.9亿元至3.3亿元
甘李药业最新公告：预计上半年净利同比增长116%-146%
证券之星 · 07-08
甘李药业最新公告：预计上半年净利同比增长116%-146%
甘李药业(603087.SH)发预增 半年度净利润2.9亿到3.3亿元 增加116.17%到145.98%
智通财经 · 07-08
甘李药业(603087.SH)发预增 半年度净利润2.9亿到3.3亿元 增加116.17%到145.98%
甘李药业：预计2024年上半年净利润同比增加116.17%到145.98%
财通社 · 07-08
甘李药业：预计2024年上半年净利润同比增加116.17%到145.98%
甘李药业07月08日主力资金流出4108万元 连续5日减仓
自选股智能写手 · 07-08
甘李药业07月08日主力资金流出4108万元 连续5日减仓
北向资金7月5日净买入甘李药业98.32万股 连续3日增持
自选股智能写手 · 07-08
北向资金7月5日净买入甘李药业98.32万股 连续3日增持
加载更多
公司概况
公司名称：
甘李药业股份有限公司
所属行业：
医药制造业
上市日期：
2020-06-29
主营业务：
甘李药业股份有限公司主要从事重组胰岛素类似物原料药及注射剂的研发、生产和销售。公司主要产品包括重组甘精胰岛素注射液、重组赖脯胰岛素注射液、精蛋白锌重组赖脯胰岛素混合注射液、门冬胰岛素注射液、门冬胰岛素30注射液五个胰岛素类似物品种。公司为唯一掌握产业化生产重组胰岛素类似物技术的中国企业，使得我国成为世界上少数能进行重组胰岛素类似物产业化生产的国家之一。
发行价格：
63.32
{"stockData":{"symbol":"603087","market":"SH","secType":"STK","nameCN":"甘李药业","latestPrice":45.21,"timestamp":1721631600000,"preClose":45.45,"halted":0,"volume":4798835,"delay":0,"floatShares":532000000,"shares":601000000,"eps":0.6435,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.24,"latestTime":"07-22 15:00:00","open":45.33,"high":45.76,"low":44.77,"amount":217000000,"amplitude":0.0218,"askPrice":45.22,"askSize":76,"bidPrice":45.21,"bidSize":18,"shortable":0,"etf":0,"ttmEps":0.6435,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721698200000},"adr":0,"adjPreClose":45.45,"symbolType":"stock","openAndCloseTimeList":[[1721611800000,1721619000000],[1721624400000,1721631600000]],"highLimit":50,"lowLimit":40.91,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":601201750,"pbRate":2.51,"roa":"--","roe":"0.89%","epsLYR":0.6,"committee":-0.321321,"marketValue":27180000000,"floatMarketCap":24064000000,"peRate":70.256413,"changeRate":-0.0053,"turnoverRate":0.009,"status":1},"requestUrl":"/m/hq/s/603087","defaultTab":"news","newsList":[{"id":"2453786850","title":"最高减重20%！礼来“替尔泊肽”在华获批，效果强过司美格鲁肽？","url":"https://stock-news.laohu8.com/highlight/detail?id=2453786850","media":"格隆汇","labels":["Product Release","Policy And Regulatory"],"top":-1,"share":"https://www.laohu8.com/m/news/2453786850?lang=zh_cn&edition=full","pubTime":"2024-07-22 10:20","pubTimestamp":1721614814,"startTime":"0","endTime":"0","summary":"竞争白热化？","market":"us","thumbnail":"https://img3.gelonghui.com/1b662-9eab396d-85aa-4a35-807e-33d8ee710c4d.jpg?guru_height=908&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/1b662-9eab396d-85aa-4a35-807e-33d8ee710c4d.jpg?guru_height=908&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/869192","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release,Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK4534","LU1551013342.USD","LU1623119135.USD","LU2328871848.SGD","LU0122379950.USD","NVO","LU0256863811.USD","300199","603087","IE00BJT1NW94.SGD","BK4532","LU0096364046.USD","LU1551013425.SGD","IE00BJJMRZ35.SGD","LU1093756325.SGD","LU0471298694.HKD","BK0183","LU0097036916.USD","LU0385154629.USD","000963","BK0187","BK0239","LU0061475181.USD","IE0002141913.USD","LU0109391861.USD","LU1804176565.USD","LI","BK4533","BK4516","LU0708995401.HKD","LU1280957306.USD","BK0188","LU0943347566.SGD","IE00BJLML261.HKD","IE00B1BXHZ80.USD","LU1061106388.HKD","BK0077","GB00BDT5M118.USD","IE0009355771.USD","LU0820561909.HKD","LU0114720955.EUR","BK0175","BK4007","LU1093756168.USD","LU0079474960.USD","LU1035775433.USD","LU0882574055.USD","LU0058720904.USD","LU0094547139.USD","IE0004445239.USD"],"gpt_icon":1},{"id":"2452405946","title":"减肥药赛道“搅局者”来了，两大巨头“硬碰硬”","url":"https://stock-news.laohu8.com/highlight/detail?id=2452405946","media":"中国基金报","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452405946?lang=zh_cn&edition=full","pubTime":"2024-07-20 00:14","pubTimestamp":1721405689,"startTime":"0","endTime":"0","summary":"中国基金报记者 冯尧国内减重赛道迎来重磅级“选手”。一直以来，礼来与诺和诺德并称“GLP-1双雄”，后者拥有“减肥神药”司美格鲁肽，已在国内获批上市。如今，随着替尔泊肽加入国内减重赛道，两大巨头将在国内“硬碰硬”。如今，随着礼来的替尔泊肽注射液在国内获批，诺和诺德和礼来两大巨头在中国百亿元级GLP-1市场的正面较量也正式展开。目前，在减重赛道上，国内企业竞争激烈。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072000172295ddb277&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072000172295ddb277&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1064130708.USD","LLY","LU0405327148.USD","600276","BK0196","688166","BK0012","LU2488822045.USD","BK0060","LU2148510915.USD","BK0239","LU0405327494.USD","LU1064131003.USD","LU1328615791.USD","BK0028","603087","BK0188","BK0183"],"gpt_icon":0},{"id":"2452176115","title":"甘李药业07月18日遭主力抛售786万元 环比增加151.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452176115","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452176115?lang=zh_cn&edition=full","pubTime":"2024-07-18 15:19","pubTimestamp":1721287158,"startTime":"0","endTime":"0","summary":"07月18日, 甘李药业股价跌0.07%，报收45.30元，成交金额1.99亿元，换手率0.83%，振幅1.76%，量比0.93。甘李药业今日主力资金净流出786万元，上一交易日主力净流出313万元，今日环比增加151.12%。该股近5个交易日下跌1.86%，主力资金累计净流出5471万元；近20日主力资金累计净流出5.71亿元，其中净流出天数为18日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071815344595d3eb21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071815344595d3eb21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603087"],"gpt_icon":0},{"id":"2451361960","title":"甘李药业：\n考虑运输、成本等因素，海外出口以原料药为主","url":"https://stock-news.laohu8.com/highlight/detail?id=2451361960","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451361960?lang=zh_cn&edition=full","pubTime":"2024-07-16 19:01","pubTimestamp":1721127677,"startTime":"0","endTime":"0","summary":"甘李药业董秘：尊敬的投资者您好，公司始终保持对行业及公司长期发展的信心，同时公司管理层将不断提高经营管理水平，做好各项生产经营工作，提升公司内在价值。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071600037429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603087","BK0239"],"gpt_icon":0},{"id":"2451955826","title":"一个赚2亿，一个赔2亿！国产胰岛素“双雄争霸赛”未完待续","url":"https://stock-news.laohu8.com/highlight/detail?id=2451955826","media":"中国商报","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451955826?lang=zh_cn&edition=full","pubTime":"2024-07-16 14:37","pubTimestamp":1721111842,"startTime":"0","endTime":"0","summary":"今年上半年，国产胰岛素“双雄”争霸赛阶段性胜负已分：甘李药业预盈利超过2亿元，打了一场“翻身仗”；通化东宝预亏损超过2亿元，交出近10年首份预亏损的中报。而其竞争对手通化东宝营业收入较去年同期减少44.66%，预计净利润亏损约2.24亿元。3双雄争霸赛下半年仍有看点国产胰岛素“双雄”各有烦恼，下半年“争霸赛”仍有看点。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407161445119f5428ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407161445119f5428ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600867","BK0196","BK0188","603087","BK0239"],"gpt_icon":0},{"id":"2451690519","title":"甘李药业07月15日遭主力抛售3272万元 环比增加110.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451690519","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451690519?lang=zh_cn&edition=full","pubTime":"2024-07-15 15:19","pubTimestamp":1721027970,"startTime":"0","endTime":"0","summary":"07月15日, 甘李药业股价跌1.72%，报收45.21元，成交金额1.83亿元，换手率0.76%，振幅2.04%，量比0.46。甘李药业今日主力资金净流出3272万元，上一交易日主力净流出1551万元，今日环比增加110.96%。|07月15日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|联动科技|5.51%|#|观想科技|4.07%|#|天地在线|3.91%|#|豪恩汽电|3.89%|#|金溢科技|3.51%|#|鼎龙科技|3.07%|#|ST舜天|2.98%|#|艾罗能源|2.57%|#|罗平锌电|2.55%|#|哈森股份|2.14%|甘李药业所在的生物制品行业，今日主力净流出2.27亿元，行业排名12/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407151534369f4d61fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407151534369f4d61fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603087","BK0239"],"gpt_icon":0},{"id":"2450280322","title":"全球首款胰岛素周制剂在美遇挫，FDA要求补充信息，今年或无望获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2450280322","media":"时代财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450280322?lang=zh_cn&edition=full","pubTime":"2024-07-12 12:31","pubTimestamp":1720758682,"startTime":"0","endTime":"0","summary":"诺和诺德告诉时代财经，上述讨论的相关建议仅关于1型糖尿病治疗。全球首款胰岛素周制剂在美上市暂遇挫折。丹麦时间7月10日，诺和诺德宣布，其收到美国食品药品监督管理局（FDA）发出的一封 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/usstock/20240712/c659751278.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["603087","BK0239"],"gpt_icon":0},{"id":"2450238901","title":"再登双榜 | 甘李药业入选《2024中国药品研发实力排行榜》系列榜单","url":"https://stock-news.laohu8.com/highlight/detail?id=2450238901","media":"甘李药业","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450238901?lang=zh_cn&edition=full","pubTime":"2024-07-11 13:39","pubTimestamp":1720676383,"startTime":"0","endTime":"0","summary":"2024中国药品研发实力奖牌在糖尿病治疗领域，甘李药业展现出了优秀的创新能力与亮眼的研发成果。参考文章：1.《2024中国药品研发综合实力排行榜 TOP100》隆重发布！在 2024 年中国胰岛素接续采购中，甘李药业的胰岛素类似物采购需求在所有中选企业中排名第二，在国内企业中排名第一。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407111458519f329baf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407111458519f329baf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603087"],"gpt_icon":0},{"id":"2450809936","title":"公司快评︱甘李药业与通化东宝业绩分化 积极适应市场变化才是真龙头","url":"https://stock-news.laohu8.com/highlight/detail?id=2450809936","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450809936?lang=zh_cn&edition=full","pubTime":"2024-07-11 12:03","pubTimestamp":1720670624,"startTime":"0","endTime":"0","summary":"通化东宝与甘李药业近期的业绩对比，恰如一面镜子，映照出市场龙头地位的脆弱性与不确定性，更昭示着，只有积极适应市场变化才是真龙头。甘李药业的成功，得益于其在接续集采中的灵活应变和策略调整。通化东宝则在新一轮胰岛素集采中未能守住既有优势，销售收入下滑，导致业绩预亏。甘李药业通过改进集采策略，抢到了更多市场份额，这是策略调整的胜利。而通化东宝未能及时应对市场变化，失去了既有优势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711120406af91c170&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711120406af91c170&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603087","600867","BK0196","BK0188"],"gpt_icon":0},{"id":"2450173088","title":"甘李药业(603087.SH)：磷酸西格列汀片预计将于下半年原研产品专利到期后上市销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2450173088","media":"格隆汇资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450173088?lang=zh_cn&edition=full","pubTime":"2024-07-10 23:46","pubTimestamp":1720626414,"startTime":"0","endTime":"0","summary":"格隆汇7月10日丨甘李药业(603087.SH)在投资者互动平台表示，GZR4是甘李药业自主研发的一款新型超长效基础胰岛素类似物，设计为每周一次给药；此外，磷酸西格列汀片是本公司自主研发的首个口服降糖药，预计将在2024年下半年原研产品相关专利到期后进行上市销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407102347079f2e0a66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407102347079f2e0a66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603087","BK0239"],"gpt_icon":0},{"id":"2450852884","title":"甘李药业07月10日主力资金流出220万元 连续7日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2450852884","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450852884?lang=zh_cn&edition=full","pubTime":"2024-07-10 15:19","pubTimestamp":1720595962,"startTime":"0","endTime":"0","summary":"07月10日, 甘李药业股价涨1.13%，报收45.63元，成交金额3.82亿元，换手率1.57%，振幅3.10%，量比0.70。甘李药业今日主力资金净流出220万元，连续7日净流出，上一交易日主力净流出1024万元，今日环比减少78.52%。该股近5个交易日上涨7.11%，主力资金累计净流出9196万元；近20日主力资金累计净流出4.74亿元，其中净流出天数为16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710153512959ce26c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710153512959ce26c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603087","BK0239"],"gpt_icon":0},{"id":"2450513310","title":"甘李药业(603087)：业绩超预期 海内外业务齐发力","url":"https://stock-news.laohu8.com/highlight/detail?id=2450513310","media":"国泰君安证券股...","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450513310?lang=zh_cn&edition=full","pubTime":"2024-07-09 10:25","pubTimestamp":1720491917,"startTime":"0","endTime":"0","summary":"业绩超预期，维持“增持”评级。海内外业务齐发力，步入加速收获期。随着集采在全国范围的陆续正式执行，在渠道库存提价、产品集采中标推动入院放量、以及产品涨价的三重推动下，Q3 起公司的扣非净利润端有望迎来进一步增厚。目前GZR18、以及胰岛素周制剂GZR4 和双胰岛素复方制剂GZR101 均处于II 期临床阶段。生产线获欧盟GMP 认证，发达市场增量可期。研发进度不及预期、产品销售推广不及预期、欧美药物审评进展不及预期、集采降价风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070910293595940861&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070910293595940861&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603087","BK0239"],"gpt_icon":0},{"id":"2450053477","title":"独家药品概念盘中拉升，甘李药业涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450053477","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450053477?lang=zh_cn&edition=full","pubTime":"2024-07-09 09:42","pubTimestamp":1720489338,"startTime":"0","endTime":"0","summary":"07月09日，独家药品概念盘中拉升，截至09点42分，独家药品概念整体指数上涨0.54%，报755.110点。从个股上来看，该概念的成分股中，甘李药业涨5.05%，特宝生物、达仁堂、华润三九涨幅居前。从资金上来看，截止发稿，独家药品概念概念主力净流入为290.63万，其中华润三九受到资金热捧，主力净流入1062.81万；拉长时间线来看，该板块近20日主力资金净流入-39.70亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709094218941f5151&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709094218941f5151&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603087"],"gpt_icon":0},{"id":"2450405347","title":"甘李药业7月8日获北向资金加仓94.28万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450405347","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450405347?lang=zh_cn&edition=full","pubTime":"2024-07-09 09:30","pubTimestamp":1720488628,"startTime":"0","endTime":"0","summary":"7月8日, 北向资金增持甘李药业94.28万股，连续4日增持。截止当日收盘，沪股通共持有甘李药业873.36万股，占流通股1.64%。沪股通增持金额前五个股分别为长江电力、澜起科技、中国平安、中国核电、农业银行。甘李药业近5个交易日下跌9.67%，沪股通累计增持229.76万股；近20个交易日下跌10.65%，沪股通累计增持11.32万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407090933559f222838&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407090933559f222838&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603087"],"gpt_icon":0},{"id":"2449727687","title":"甘李药业：预计2024年1-6月归属净利润盈利2.9亿元至3.3亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449727687","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449727687?lang=zh_cn&edition=full","pubTime":"2024-07-08 18:01","pubTimestamp":1720432875,"startTime":"0","endTime":"0","summary":"证券之星消息，甘李药业发布业绩预告，预计2024年1-6月归属净利润盈利2.9亿元至3.3亿元。甘李药业2024年一季报显示，公司主营收入5.6亿元，同比上升0.42%；归母净利润9600.43万元，同比上升95.04%；扣非净利润1716.93万元，同比下降42.93%；负债率7.49%，投资收益226.53万元，财务费用-2006.54万元，毛利率72.83%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800024741.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603087"],"gpt_icon":0},{"id":"2449729534","title":"甘李药业最新公告：预计上半年净利同比增长116%-146%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449729534","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449729534?lang=zh_cn&edition=full","pubTime":"2024-07-08 16:50","pubTimestamp":1720428611,"startTime":"0","endTime":"0","summary":"甘李药业公告，公司预计2024年半年度实现净利润2.9亿元到3.3亿元，同比增加116.17%到145.98%。2024年上半年，公司营业收入较上年同期实现稳步增长，主要系国内胰岛素制剂产品销量保持稳定增长。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800021494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603087","BK0239"],"gpt_icon":0},{"id":"2449726201","title":"甘李药业(603087.SH)发预增 半年度净利润2.9亿到3.3亿元 增加116.17%到145.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449726201","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449726201?lang=zh_cn&edition=full","pubTime":"2024-07-08 16:44","pubTimestamp":1720428252,"startTime":"0","endTime":"0","summary":"智通财经APP讯，甘李药业(603087.SH)披露2024年半年度业绩预增公告，该公司预计报告期归属于母公司所有者的净利润为2.9亿元到3.3亿元，同比增加116.17%到145.98%。归属于母公司所有者的扣除非经常性损益的净利润为1.1亿元至1.4亿元，同比增加7.61%到36.96%。2024年上半年，该公司营业收入较上年同期实现稳步增长，主要系国内胰岛素制剂产品销量保持稳定增长。此外，非经常性损益对净利润的影响较上年显著增加，主要系报告期内受二级市场波动影响，公司持有的交易性金融资产公允价值变动收益，以及处置交易性金融资产取得的投资收益较上年同期大幅增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1146925.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603087"],"gpt_icon":0},{"id":"2449726109","title":"甘李药业：预计2024年上半年净利润同比增加116.17%到145.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449726109","media":"财通社","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449726109?lang=zh_cn&edition=full","pubTime":"2024-07-08 16:39","pubTimestamp":1720427940,"startTime":"0","endTime":"0","summary":"甘李药业公告，公司预计2024年上半年实现归属于母公司所有者的净利润为2.9亿元至3.3亿元，同比增加116.17%到145.98%。扣除非经常性损益后的净利润为1.1亿元至1.4亿元，同比增加7.61%到36.96%。业绩增长主要由于营业收入和非经常性损益的增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708164026958f413f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708164026958f413f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603087"],"gpt_icon":0},{"id":"2449506740","title":"甘李药业07月08日主力资金流出4108万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2449506740","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449506740?lang=zh_cn&edition=full","pubTime":"2024-07-08 15:19","pubTimestamp":1720423160,"startTime":"0","endTime":"0","summary":"07月08日, 甘李药业股价跌3.76%，报收42.22元，成交金额3.60亿元，换手率1.58%，振幅5.93%，量比0.85。甘李药业今日主力资金净流出4108万元，连续5日净流出，上一交易日主力净流出2184万元，今日环比增加88.10%。该股近5个交易日下跌9.67%，主力资金累计净流出2.57亿元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出4.74亿元，其中净流出天数为16日。净流出前三个股分别为智飞生物、甘李药业、长春高新。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708153656958eec0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708153656958eec0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603087"],"gpt_icon":0},{"id":"2449718191","title":"北向资金7月5日净买入甘李药业98.32万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2449718191","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449718191?lang=zh_cn&edition=full","pubTime":"2024-07-08 09:30","pubTimestamp":1720402226,"startTime":"0","endTime":"0","summary":"7月5日, 北向资金增持甘李药业98.32万股，连续3日增持。截止当日收盘，沪股通共持有甘李药业779.08万股，占流通股1.46%。沪股通增持金额前五个股分别为国投电力、中金黄金、中国核电、川投能源、中国石油。甘李药业近5个交易日下跌5.29%，沪股通累计增持121.49万股；近20个交易日下跌7.91%，沪股通累计增持22.67万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407080933099f1b5fe9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407080933099f1b5fe9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603087","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-06-29","address":"北京市通州区漷县镇南凤西一路8号","stockEarnings":[{"period":"1week","weight":-0.012},{"period":"1month","weight":-0.0648},{"period":"3month","weight":0.0889},{"period":"6month","weight":0.0551},{"period":"1year","weight":0.0999},{"period":"ytd","weight":-0.133}],"companyName":"甘李药业股份有限公司","boardCode":"AI0027","perCapita":"6353股","boardName":"医药制造业","registeredCapital":"60106万元","compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.0118},{"period":"3month","weight":-0.0271},{"period":"6month","weight":0.053},{"period":"1year","weight":-0.0591},{"period":"ytd","weight":0.0025}],"survey":" 甘李药业股份有限公司主要从事重组胰岛素类似物原料药及注射剂的研发、生产和销售。公司主要产品包括重组甘精胰岛素注射液、重组赖脯胰岛素注射液、精蛋白锌重组赖脯胰岛素混合注射液、门冬胰岛素注射液、门冬胰岛素30注射液五个胰岛素类似物品种。公司为唯一掌握产业化生产重组胰岛素类似物技术的中国企业，使得我国成为世界上少数能进行重组胰岛素类似物产业化生产的国家之一。","serverTime":1721655642080,"listedPrice":63.32,"stockholders":"83780人(较上一季度减少3.14%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"甘李药业(603087)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供甘李药业(603087)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"甘李药业,603087,甘李药业股票,甘李药业股票老虎,甘李药业股票老虎国际,甘李药业行情,甘李药业股票行情,甘李药业股价,甘李药业股市,甘李药业股票价格,甘李药业股票交易,甘李药业股票购买,甘李药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"甘李药业(603087)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供甘李药业(603087)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}